These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9592979

  • 1. Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography.
    Biescas H, Gensana M, Fernández J, Ristol P, Massot M, Watson E, Vericat F.
    Haematologica; 1998 Apr; 83(4):305-11. PubMed ID: 9592979
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
    Ristol P, Gensana M, Fernández J, Massot M, Biescas H, Darling A, Jorquera JI, Vericat F.
    Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353
    [Abstract] [Full Text] [Related]

  • 3. Viral safety of Nanogam, a new 15 nm-filtered liquid immunoglobulin product.
    Terpstra FG, Parkkinen J, Tölö H, Koenderman AH, Ter Hart HG, von Bonsdorff L, Törmä E, van Engelenburg FA.
    Vox Sang; 2006 Jan; 90(1):21-32. PubMed ID: 16359352
    [Abstract] [Full Text] [Related]

  • 4. Pasteurized, monoclonal antibody factor VIII concentrate: establishing a new standard for purity and viral safety of plasma-derived concentrates.
    Goldsmith JC.
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):203-15. PubMed ID: 10759015
    [Abstract] [Full Text] [Related]

  • 5. Inactivation and clearance of viruses during the manufacture of high purity factor IX.
    Johnston A, Macgregor A, Borovec S, Hattarki M, Stuckly K, Anderson D, Goss NH, Oates A, Uren E.
    Biologicals; 2000 Sep; 28(3):129-36. PubMed ID: 10964439
    [Abstract] [Full Text] [Related]

  • 6. [Validation of the virus inactivation capacity of a procedure of human plasma albumin purification by chromatography].
    Stoltz JF, Geschier C, Rivat C, Sertillanges P, Grandgeorges M, Liautaud J, Regnault V, Dumont L.
    Ann Pharm Fr; 1993 Sep; 51(2):78-93. PubMed ID: 8250488
    [Abstract] [Full Text] [Related]

  • 7. [Properties and virus safety of a pasteurized antithrombin III concentrate].
    Karges HE, Fuhge P, Heimburger N.
    Arzneimittelforschung; 1987 Jul; 37(7):756-8. PubMed ID: 2823838
    [Abstract] [Full Text] [Related]

  • 8. Viral validation of the manufacturing process of high purity albumin from placentas.
    Grandgeorge M, Véron JL.
    Dev Biol Stand; 1993 Jul; 81():237-44. PubMed ID: 8174808
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Purification and large-scale preparation of antithrombin III.
    Hoffman DL.
    Am J Med; 1989 Sep 11; 87(3B):23S-26S. PubMed ID: 2801726
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pasteurization as an efficient method to inactivate blood borne viruses in factor VIII concentrates.
    Hilfenhaus J, Weidmann E.
    Arzneimittelforschung; 1986 Apr 11; 36(4):621-5. PubMed ID: 3013213
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Manufacturing process of anti-thrombin III concentrate: viral safety validation studies and effect of column re-use on viral clearance.
    Morrica A, Nardini C, Falbo A, Bailey AC, Bucci E.
    Biologicals; 2003 Sep 11; 31(3):165-73. PubMed ID: 12935804
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of membrane adsorber (MA) based purification schemes for the down-stream processing of recombinant h-AT III.
    Reif OW, Freitag R.
    Bioseparation; 1994 Dec 11; 4(6):369-81. PubMed ID: 7765681
    [Abstract] [Full Text] [Related]

  • 19. Second-generation nanofiltered plasma-derived mannan-binding lectin product: process and characteristics.
    Laursen I, Houen G, Højrup P, Brouwer N, Krogsøe LB, Blou L, Hansen PR.
    Vox Sang; 2007 May 11; 92(4):338-50. PubMed ID: 17456158
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.